Skip to main content
Top
Published in: Critical Care 2/2006

Open Access 01-04-2006 | Research

Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion

Authors: Zaccaria Ricci, Claudio Ronco, Alessandra Bachetoni, Giuseppe D'amico, Stefano Rossi, Elisa Alessandri, Monica Rocco, Paolo Pietropaoli

Published in: Critical Care | Issue 2/2006

Login to get access

Abstract

Introduction

The best modality, for continuous renal replacement therapy (CRRT) is currently uncertain and it is poorly understood how transport of different solutes, whether convective or diffusive, changes over time.

Methods

We conducted a prospective cross over study in a cohort of critically ill patients, comparing small (urea and creatinine) and middle (β2 microglobulin) molecular weight solute clearance, filter lifespan and membrane performance over a period of 72 hours, during 15 continuous veno-venous dialysis (CVVHD) and 15 continuous veno-venous hemofiltration (CVVH)sessions. Both modalities were administered based on a prescription of 35 ml/kg/h and using polyacrylonitrile filters.

Results

Median filter lifespan was significantly longer during CVVHD (37 hours, interquartile range (IQR) 19.5 to 72.5) than CVVH (19 hours, IQR 12.5 to 28) (p = 0.03). Median urea time weighted average (TWA) clearances were not significantly different during CVVH (31.6 ml/minute, IQR 23.2 to 38.9) and CVVHD (35.7 ml/minute, IQR 30.1 to 41.5) (p = 0.213). Similar results were found for creatinine: 38.1 ml/minute, IQR 28.5 to 39, and 35.6 ml/minute, IQR 26 to 43 (p = 0.917), respectively. Median β2m TWA clearance was higher during convective (16.3 ml/minute, IQR 10.9 to 23) than diffusive (6.27 ml/minute, IQR 1.6 to 14.9) therapy; nonetheless this difference did not reach statistical significance (p = 0.055). Median TWA adsorptive clearance of β2m appeared to have scarce impact on overall solute removal (0.012 ml/minute, IQR -0.09 to 0.1, during hemofiltration versus -0.016 ml/minute, IQR -0.08 to 0.1 during dialysis; p = 0.79). Analysis of clearance modification over time did not show significant modifications of urea, creatinine and β2m clearance in the first 48 hours during both treatments. In the CVVHD group, the only significant difference was found for β2m between 72 hours and baseline clearance.

Conclusion

Polyacrylonitrile filters during continuous hemofiltration and continuous hemodialysis delivered at 35 ml/kg/h are comparable in little and middle size solute removal. CVVHD appears to warrant longer CRRT sessions. The capacity of both modalities for removing such molecules is maintained up to 48 hours.
Appendix
Available only for authorised users
Literature
1.
go back to reference Venkataraman R, Subramanian S, Kellum JA: Clinical review: Extracorporeal blood purification in severe sepsis. Crit Care 2003, 7: 139-145. 10.1186/cc1889PubMedCentralCrossRefPubMed Venkataraman R, Subramanian S, Kellum JA: Clinical review: Extracorporeal blood purification in severe sepsis. Crit Care 2003, 7: 139-145. 10.1186/cc1889PubMedCentralCrossRefPubMed
2.
go back to reference Ricci Z, Ronco C: Renal replacement II: dialysis dose. Crit Care Clin 2005, 21: 357-366. 10.1016/j.ccc.2005.01.007CrossRefPubMed Ricci Z, Ronco C: Renal replacement II: dialysis dose. Crit Care Clin 2005, 21: 357-366. 10.1016/j.ccc.2005.01.007CrossRefPubMed
3.
go back to reference Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000, 356: 26-30. 10.1016/S0140-6736(00)02430-2CrossRefPubMed Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000, 356: 26-30. 10.1016/S0140-6736(00)02430-2CrossRefPubMed
4.
go back to reference Bouman C, Oudemans-van Straaten HM, Tijssen J, Zandstra D, Kesecioglu J: Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial. Crit Care Med 2002, 30: 2205-2211. 10.1097/00003246-200210000-00005CrossRefPubMed Bouman C, Oudemans-van Straaten HM, Tijssen J, Zandstra D, Kesecioglu J: Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial. Crit Care Med 2002, 30: 2205-2211. 10.1097/00003246-200210000-00005CrossRefPubMed
5.
go back to reference De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999, 10: 846-853.PubMed De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999, 10: 846-853.PubMed
6.
go back to reference Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D: Comparison of mortality in end stage renal disease patients on convective and diffusive extracorporeal treatments: The Registro Lombardo Dialisi e Trapianto. Kidney Int 1999, 55: 286-293. 10.1046/j.1523-1755.1999.00236.xCrossRefPubMed Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D: Comparison of mortality in end stage renal disease patients on convective and diffusive extracorporeal treatments: The Registro Lombardo Dialisi e Trapianto. Kidney Int 1999, 55: 286-293. 10.1046/j.1523-1755.1999.00236.xCrossRefPubMed
7.
go back to reference Ricci Z, Salvatori G, Bonello M, Bolgan I, D'Amico G, Dan M, Piccinni P, Ronco C: In vivo validation of the adequacy calculator for continuous renal replacement therapies. Critical Care 2005, 9: R266-R273. 10.1186/cc3517PubMedCentralCrossRefPubMed Ricci Z, Salvatori G, Bonello M, Bolgan I, D'Amico G, Dan M, Piccinni P, Ronco C: In vivo validation of the adequacy calculator for continuous renal replacement therapies. Critical Care 2005, 9: R266-R273. 10.1186/cc3517PubMedCentralCrossRefPubMed
8.
go back to reference Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003, 29: 575-578. 10.1007/s00134-003-1857-1CrossRefPubMed Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003, 29: 575-578. 10.1007/s00134-003-1857-1CrossRefPubMed
9.
go back to reference Venkataraman R, Kellum JA, Palevsky P: Dosing patterns for CRRT at a large academic medical center in the United States. J Crit Care 2002, 17: 246-250. 10.1053/jcrc.2002.36757CrossRefPubMed Venkataraman R, Kellum JA, Palevsky P: Dosing patterns for CRRT at a large academic medical center in the United States. J Crit Care 2002, 17: 246-250. 10.1053/jcrc.2002.36757CrossRefPubMed
10.
go back to reference Ronco C, Ghezzi P, Bowry S: Membranes for hemodialysis. In Replacement of Renal Function by Dialysis. 5th edition. Edited by: Horl W, Koch K, Lindsay R, Ronco C, Winchester J. Kluwer Academic Publishers, Dordrecht; 2004:311-323. Ronco C, Ghezzi P, Bowry S: Membranes for hemodialysis. In Replacement of Renal Function by Dialysis. 5th edition. Edited by: Horl W, Koch K, Lindsay R, Ronco C, Winchester J. Kluwer Academic Publishers, Dordrecht; 2004:311-323.
11.
go back to reference Bellomo R, Ronco C, Kellum JA, Mehta R, Palevsky P, the ADQI workgroup: Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 2004, 8: R204-R212. 10.1186/cc2872PubMedCentralCrossRefPubMed Bellomo R, Ronco C, Kellum JA, Mehta R, Palevsky P, the ADQI workgroup: Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 2004, 8: R204-R212. 10.1186/cc2872PubMedCentralCrossRefPubMed
12.
go back to reference Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady J, Pinsky M: Diffusive vs. convective therapy: Effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998, 26: 1995-2000. 10.1097/00003246-199812000-00027CrossRefPubMed Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady J, Pinsky M: Diffusive vs. convective therapy: Effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998, 26: 1995-2000. 10.1097/00003246-199812000-00027CrossRefPubMed
13.
go back to reference Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Muller JM, Baumann G, et al.: Renal replacement therapy with high cutoff hemofilters: impact of convection and diffusive on cytokine clearances and protein status. Am J Kidney Dis 2004, 43: 444-453. 10.1053/j.ajkd.2003.11.006CrossRefPubMed Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Muller JM, Baumann G, et al.: Renal replacement therapy with high cutoff hemofilters: impact of convection and diffusive on cytokine clearances and protein status. Am J Kidney Dis 2004, 43: 444-453. 10.1053/j.ajkd.2003.11.006CrossRefPubMed
14.
go back to reference Cole L, Bellomo R, Davenport P, Tipping P, Ronco C: Cytokine removal during continuous renal replacement therapy: An ex vivo comparison of convection and diffusion. Int J Artif Organs 2004, 27: 388-397.PubMed Cole L, Bellomo R, Davenport P, Tipping P, Ronco C: Cytokine removal during continuous renal replacement therapy: An ex vivo comparison of convection and diffusion. Int J Artif Organs 2004, 27: 388-397.PubMed
15.
go back to reference Kay J, Hano JE: Muscoloskeletal and rheumatic diseases. In Handbook of Dialysis. 3rd edition. Edited by: Daugirdas JT, Blake PG, Todd SI. Lippincott Williams and Wilkins, Philadelphia; 2001:637-651. Kay J, Hano JE: Muscoloskeletal and rheumatic diseases. In Handbook of Dialysis. 3rd edition. Edited by: Daugirdas JT, Blake PG, Todd SI. Lippincott Williams and Wilkins, Philadelphia; 2001:637-651.
16.
go back to reference Cariou A, Vinsonneau C, Dhainaut JF: Adjunctive therapies in sepsis: An evidence-based review. Crit Care Med 2004,32(Suppl):S562-S570. 10.1097/01.CCM.0000142910.01076.A5CrossRefPubMed Cariou A, Vinsonneau C, Dhainaut JF: Adjunctive therapies in sepsis: An evidence-based review. Crit Care Med 2004,32(Suppl):S562-S570. 10.1097/01.CCM.0000142910.01076.A5CrossRefPubMed
17.
go back to reference Kutsogiannis D, Gibney N, Stollery D, Gao J: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Intl 2005, 67: 2361-2367. 10.1111/j.1523-1755.2005.00342.xCrossRef Kutsogiannis D, Gibney N, Stollery D, Gao J: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Intl 2005, 67: 2361-2367. 10.1111/j.1523-1755.2005.00342.xCrossRef
Metadata
Title
Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion
Authors
Zaccaria Ricci
Claudio Ronco
Alessandra Bachetoni
Giuseppe D'amico
Stefano Rossi
Elisa Alessandri
Monica Rocco
Paolo Pietropaoli
Publication date
01-04-2006
Publisher
BioMed Central
Published in
Critical Care / Issue 2/2006
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc4903

Other articles of this Issue 2/2006

Critical Care 2/2006 Go to the issue